sQuiz your knowledge! Itchy, polymorphic skin lesions in a patient with clear cell renal carcinoma Nivolumab-induced bullous pemphigoid

被引：0
|
作者：
Wojcik, Ewa [1 ]
Stefaniak, Aleksandra [1 ]
Szepietowski, Jacek C. [1 ]
机构：
[1] Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Ul Chalubinskiego 1, PL-50368 Wroclaw, Poland
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2020年 / 30卷 / 06期
关键词：
D O I：
10.1684/ejd.2020.3938
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：769 / 770
页数：2
相关论文
共 50 条
  • [31] Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report
    Kikuchi, Fumi
    Saheki, Takanobu
    Imachi, Hitomi
    Kobayashi, Toshihiro
    Fukunaga, Kensaku
    Ibata, Tomohiro
    Sato, Seisuke
    Ban, Natsuki
    Lyu, Jingya
    Japar, Salimah
    Murao, Koji
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [32] Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy
    Gergi, Mansour
    Landry, Kara K.
    Ades, Steven
    Barry, Maura
    Zakai, Neil A.
    Herrera, Diego Adrianzen
    ONCOLOGIST, 2020, 25 (12): : 1009 - 1012
  • [33] Nivolumab induced vitiligo-like lesions in a patient with metastatic squamous cell carcinoma of the lung
    Nishino, Kazumi
    Ohe, Shuichi
    Kitamura, Masanori
    Kunimasa, Kei
    Kimura, Iniadoka
    Inoue, Takako
    Tamiya, Motohiro
    Kumagai, Toru
    Nakatsuka, Shin-ichi
    Isei, Taiki
    Imamura, Fumio
    JOURNAL OF THORACIC DISEASE, 2018, 10 (06) : E481 - E484
  • [34] A RARE CASE OF IPILIMUMAB/NIVOLUMAB-INDUCED MYOCARDITIS COMPLICATED BY HIGH GRADE ATRIOVENTRICULAR BLOCK IN A PATIENT WITH METASTATIC RENAL CELL CANCER
    Logiacco, A.
    Basile, P.
    Mandunzio, D.
    Gentile, M.
    Carella, M.
    Memeo, R.
    Santobuono, V
    Forleo, C.
    Ciccone, M.
    Guaricci, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26 : ii175 - ii175
  • [35] Pembrolizumab-Induced Rhabdomyolysis in a Clear Cell Renal Cell Carcinoma Patient: A Case Report
    Altermanini, Mohammad
    Ali, Khaled
    Alwassiti, Wisam
    Almohtasib, Suliman
    Omar, Nabil E.
    Zafar, Abdulaziz
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 728 - 733
  • [36] Fatal fulminant hepatitis induced by combined ipilimumab and nivolumab therapy despite favorable histologic response and confirmed by autopsy in a patient with clear cell renal cell carcinoma
    Kubo, Terufumi
    Sugawara, Taro
    Shinkawa, Tomoyo
    Kurisu, Tomoyo
    Kouzen, Nodoka
    Tanaka, Toshiaki
    Fukuta, Fumimasa
    Yamasaki, Kouji
    Sugita, Shintaro
    Matsuo, Kazuhiko
    Morita, Rena
    Hirohashi, Yoshihiko
    Tsukahara, Tomohide
    Kanaseki, Takayuki
    Hasegawa, Tadashi
    Masumori, Naoya
    Torigoe, Toshihiko
    IMMUNOLOGICAL MEDICINE, 2021, 44 (02) : 136 - 141
  • [37] Hand-Foot Skin Reaction Secondary to Sunitinib in a Patient With Metastatic Clear Cell Renal Cell Carcinoma
    Ferez-Blando, Karen
    Castro-Alonso, Francisco J.
    Dominguez-Cherit, Judith
    Bourlon, Maria T.
    ONCOLOGY-NEW YORK, 2021, 35 (05): : 272 - 276
  • [38] Cytokine Release Syndrome with Relative Adrenal Insufficiency Induced by Ipilimumab and Nivolumab Combination Therapy for Clear Cell Renal Cell Carcinoma
    Yamamoto, Kohei
    Shiotsu, Shinsuke
    Sasakura, Misaki
    Tanaka, Shunya
    Goda, Shiho
    Tsuji, Taisuke
    Yuba, Tatsuya
    Takumi, Chieko
    Hiraoka, Noriya
    INTERNAL MEDICINE, 2024, 63 (19) : 2703 - 2707
  • [39] A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management
    Lopez, Adriana T.
    Geskin, Larisa
    ONCOLOGIST, 2018, 23 (10): : 1119 - 1126
  • [40] Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo-progression in clear cell renal cell carcinoma: A case report
    Furubayashi, Nobuki
    Negishi, Takahito
    Uozumi, Tomoharu
    Takamatsu, Dai
    Shiraishi, Koichi
    Hirose, Daisuke
    Nakamura, Motonobu
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (02) : 304 - 308
12345